Give 365 Days of Hope.
LBF365: Because Kids Fight Brain Cancer Every Day.
Children fighting brain cancer need breakthroughs every day of the year. When 26 new donors join LBF365 this season, a generous supporter will contribute an additional $5,000 to power pediatric brain cancer research.
Give a gift that lasts all year long: 365 days of hope. Sign up today.

Every Day Matters. So Does Your Support.
LBF365 is the Lilabean Foundation's giving program supporting research for children with brain cancer every single day of the year.
Every day, 13 children in the U.S. are diagnosed with a malignant brain tumor. Behind each number is a child missing school, a parent facing impossible choices, and a family whose life has been turned upside down. LBF365 is your opportunity to stand with these families—not just today, but all year long. Your gift demonstrates your commitment to ensuring funds are available for critical research and creating a future where every child with brain cancer has a chance to grow up and thrive.
Frequently asked questions
Why Become a Monthly Donor?
Is my donation secure?
Do I get a receipt?
How is my personal data handled?
Can I make a monthly donation in honor of any LBF Hero?





“Around 5,000 children this year will have their lives completely turned upside down by the words 'brain cancer.' We never thought in a million years that in 2023 our family and our sweet son would be included in that statistic, but we were. We are beyond lucky to be able to have our son still with us today, but we would be remiss to say that brain cancer doesn’t stay with us every single day of the year. We are in this fight 365 days a year, and we will forever be. One day, we were not a brain cancer family, but the next, we were. Do not wait till someone you love is diagnosed to join this fight.”
— Cara Sarubin, Mom of LBF Hero, Cameron

Be the reason a brain cancer family is hopeful— every single day.
Your monthly gift powers childhood brain cancer research, discovery of safer and more effective treatments, and change towards personalized medicine.
